Andrea Lauterio
Overview
Explore the profile of Andrea Lauterio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
958
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Incarbone N, De Carlis R, Centonze L, Bernasconi D, Valsecchi M, Lauterio A, et al.
Dig Liver Dis
. 2023 Jun;
55(12):1690-1698.
PMID: 37316362
Objective: To investigate the influence of postoperative complications on tumor-related (TRD), disease-free survival (DFS) and overall survival (OS) in patients undergoing liver transplant (LT) for hepatocellular carcinoma (HCC). Methods: We...
22.
Centonze L, Di Bella C, Giacomoni A, Silvestre C, De Carlis R, Frassoni S, et al.
Transplantation
. 2023 May;
107(9):2009-2017.
PMID: 37195281
Background: Although laparoscopic donor nephrectomy (LDN) represents the gold-standard technique for kidney living donation, robotic donor nephrectomy (RDN) settled as another appealing minimally invasive technique over the past decades. A...
23.
Di Sandro S, Sposito C, Ravaioli M, Lauterio A, Magistri P, Bongini M, et al.
Transplantation
. 2023 Apr;
107(9):1965-1975.
PMID: 37022089
Background: Early-stage hepatocellular carcinoma could benefit from upfront liver resection (LR) or liver transplantation (LT), but the optimal strategy in terms of tumor-related outcomes is still debated. We compared the...
24.
Eden J, Sousa Da Silva R, Cortes-Cerisuelo M, Croome K, De Carlis R, Hessheimer A, et al.
J Hepatol
. 2023 Feb;
78(5):1007-1016.
PMID: 36740047
Background & Aims: Liver graft utilization rates are a hot topic due to the worldwide organ shortage and the increasing number of transplant candidates on waiting lists. Liver perfusion techniques...
25.
Lauterio A, De Carlis R, Centonze L, Merli M, Valsecchi M, Monti G, et al.
Transpl Infect Dis
. 2023 Jan;
25(3):e14025.
PMID: 36715644
No abstract available.
26.
Centonze L, Gorga G, De Carlis R, Bernasconi D, Lauterio A, Carbonaro L, et al.
Transplantation
. 2022 Nov;
107(4):913-924.
PMID: 36367922
Background: The impact of spontaneous portosystemic shunts (SPSSs) on natural history of cirrhotic patients was recently evaluated through the measurement of total shunt area (TSA), a novel tool that allows...
27.
Melandro F, De Carlis R, Torri F, Lauterio A, De Simone P, De Carlis L, et al.
Medicina (Kaunas)
. 2022 Oct;
58(10).
PMID: 36295593
With the increased use of extended-criteria donors, machine perfusion became a beneficial alternative to cold storage in preservation strategy for donor livers with the intent to expand donor pool. Both...
28.
Patrono D, De Carlis R, Gambella A, Farnesi F, Podesta A, Lauterio A, et al.
Liver Transpl
. 2022 Sep;
29(5):508-520.
PMID: 36117430
End-ischemic viability testing by normothermic machine perfusion (NMP) represents an effective strategy to recover liver grafts having initially been discarded for liver transplantation (LT). However, its results in the setting...
29.
Rossotti R, Merli M, Mazzarelli C, De Carlis R, Travi G, Vecchi M, et al.
Dig Liver Dis
. 2022 Jun;
55(2):268-275.
PMID: 35644890
Background: Liver transplantation (LT) represents the best therapeutic option for hepatocellular carcinoma (HCC) and end-stage liver disease (ESLD). Although HIV infection does not seem to lower survival rates, HCV and...
30.
Artzner T, Conti S, Cortesi P, Sacleux S, Fernandez J, Morelli M, et al.
Liver Transpl
. 2022 May;
28(9):1429-1440.
PMID: 35544360
There is growing evidence that liver transplantation (LT) is the most effective treatment for acute-on-chronic liver failure grade-3 (ACLF-3). This study examines whether and how this evidence translates into practice...